TRENDING NEWS
  • UN Tourism Members advance agenda for Europe as region leads global recovery
  • Sustainable tourism market to grow at 14% CAGR by 2032
  • UN Tourism launches investment guidelines for Albania
  • 'UAE, Egypt, Vietnam popular among Indian solo travellers'
  • Oman Air mulls single aircraft-type operating model
  • Etihad Airways adds Al Qassim to its route network

Hope to Resolve Issues Faced by Indians Vaccinated with Covishield Travelling to EU Soon: Poonawalla

Adar Poonawalla, Chief Executive Officer, Serum Institute of India said he has taken up the issues faced by Indians who have taken the Covishield jab travelling to the European Union at highest levels and hoped to resolve them soon. Covishield is the Oxford University-AstraZeneca vaccine manufactured in India by the Pune-based vaccine maker.

“I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries,” Poonawalla said in a tweet. As of now European Union (EU) recognises Vaxzevria (previously COVID-19 Vaccine AstraZeneca, Oxford).

The other vaccines approved by the European Medicine Agency are Comirnaty by BioNTech-Pfizer, Moderna and Janssen (Johnson & Johnson). (Source: News18)

 

Read Previous

Vietnam’s Ha Long Bay to reduce quarantine for vaccinated foreign tourists

Read Next

FM announces financial support to over 11,000 registered tourist guides, stakeholders to revive tourism sector

Download Magazine